111 Colchester Ave, Burlington, VT, 05401 · (802) 847-0000
Beds
469
FY 2025
Star rating
4 of 5
Patient survey: 4 of 5
Net patient revenue
$1.43B
FY 2025
Net income
-$212.0M
Patient care margin -71.0%
Discharges
21,027
Occupancy 80.0%
Clinicians
1,617
From the hospital's yearly cost reports (fiscal years as the hospital reports them)
Locations are shown at the center of the ZIP code.
US dollars as reported. Patient care margin = net patient revenue minus operating expenses, before other income such as grants, donations and investments.
| Fiscal year | Net patient revenue | Operating expenses | Patient care margin | Net income | Discharges | Uncompensated care | Medicare days | Medicaid days |
|---|---|---|---|---|---|---|---|---|
| 2025 | $1.43B | $2.45B | -71.0% | -$212.0M | 21,027 | $26.8M | 27.0% | 23.1% |
Official hospital quality measures with the national median across hospitals. For ratios, 1.00 means as many cases as expected.
| Death rate after heart bypass surgery | 1.8% | US median 2.3% |
| Death rate for COPD patients | 9.5% | US median 8.5% |
| Death rate for heart attack patients | 12% | US median 11.8% |
| Death rate for heart failure patients | 13% | US median 11% |
| Hospital-wide death rate within 30 days | 3% | US median 3.9% |
| Death rate for pneumonia patients | 14% | US median 15.2% |
| Death rate for stroke patients |
Medicare clinicians who list this hospital, by specialty
Inpatient stays by diagnosis related group (DRG), 2024
Official US government data: hospital records, ownership records, yearly cost reports and quality measures, linked by the hospital's CCN and NPI. Financials are for fiscal years as reported by the hospital.
Medicare clinicians who work here
| 2024 | $1.81B | $2.34B | -29.3% | -$115.7M | 21,056 | $22.7M | 29.9% | 23.4% |
| 2023 | $1.85B | $2.06B | -11.3% | $119.9M | 20,252 | $15.6M | 30.5% | 24.7% |
| 2022 | $1.31B | $1.85B | -41.2% | -$147.2M | 19,703 | $20.9M | 32.5% | 24.2% |
| 2021 | $1.13B | $1.57B | -38.7% | $72.4M | 19,751 | $13.6M | 36.1% | 24.1% |
| 2020 | $1.03B | $1.46B | -41.5% | $35.5M | 19,787 | $14.9M | 38.0% | 15.3% |
| 9.8% |
| US median 11.6% |
| Readmission rate after heart bypass surgery | 10.5% | US median 10.9% |
| Readmission rate for COPD | 20.9% | US median 19.8% |
| Readmission rate after a heart attack | 14.2% | US median 14.4% |
| Readmission rate for heart failure | 19.5% | US median 21.3% |
| Readmission rate after hip or knee replacement | 6.1% | US median 5.8% |
| Readmission rate for pneumonia | 16.6% | US median 17.2% |
| Complications after hip or knee replacement | 4.1% | US median 4.1% |
| Serious complications (patient safety composite) | 1.34 | US median 0.96 · worse |
| C. diff intestinal infections (ratio to expected) | 0.50 | US median 0.28 · better |
| Central line bloodstream infections (ratio to expected) | 0.71 | US median 0.48 |
| Surgical site infections after colon surgery (ratio to expected) | 1.29 | US median 0.72 |
| Surgical site infections after hysterectomy (ratio to expected) | 0.00 | US median 0.81 |
| MRSA bloodstream infections (ratio to expected) | 0.15 | US median 0.60 · better |
| Catheter urinary tract infections (ratio to expected) | 1.13 | US median 0.40 |
| Doctors always communicated well | 80% | US median 79% |
| Nurses always communicated well | 82% | US median 80% |
| Patient survey summary star rating | 4 of 5 | US median 3 of 5 |
| Area around the room always quiet at night | 54% | US median 59% |
| Patients who rated the hospital 9 or 10 out of 10 | 73% | US median 72% |
| Room and bathroom always clean | 68% | US median 73% |
| Patients who would definitely recommend the hospital | 76% | US median 71% |
| Patients who left the emergency department before being seen | 3% | US median 1% |
| Median time in the emergency department before leaving (minutes) | 259 min | US median 148 min |
| Patients prescribed 2 or more opioids or opioids with benzodiazepines at discharge | 15% | US median 15% |
| Patients who got appropriate care for severe sepsis and septic shock | 48% | US median 65% |
| Healthcare workers given the flu vaccine | 65% | US median 79% |
| 159 |
| $42,272.87 |
| $4,213.06 |
| $9,973.97 |
| DRG 267 ENDOVASCULAR CARDIAC VALVE REPLACEMENT AND SUPPLEMENT PROCEDURES WITHOUT MCC | 156 | $150,267.72 | $27,731.74 | $40,566.75 |
| DRG 193 SIMPLE PNEUMONIA AND PLEURISY WITH MCC | 106 | $41,838.49 | $6,115.09 | $9,867.73 |
| DRG 280 ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH MCC | 104 | $52,843.42 | $7,565.61 | $12,400.10 |
| DRG 177 RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH MCC | 100 | $56,298.11 | $6,516.64 | $12,667.88 |
| DRG 065 INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH CC OR TPA IN 24 HOURS | 84 | $53,726.32 | $4,417.31 | $7,474.08 |
| DRG 322 PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH INTRALUMINAL DEVICE WITHOUT MCC | 84 | $80,916.25 | $9,094.00 | $12,904.99 |
| DRG 025 CRANIOTOMY AND ENDOVASCULAR INTRACRANIAL PROCEDURES WITH MCC | 73 | $128,440.52 | $28,599.77 | $37,824.45 |
| DRG 853 INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURES WITH MCC | 71 | $153,946.68 | $36,866.68 | $40,556.82 |
| DRG 064 INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH MCC | 68 | $74,545.56 | $11,630.88 | $15,695.20 |
| DRG 847 CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH CC | 68 | $37,380.26 | $6,082.15 | $12,158.78 |
| DRG 378 GASTROINTESTINAL HEMORRHAGE WITH CC | 68 | $33,095.07 | $4,072.81 | $7,294.77 |
| DRG 885 PSYCHOSES | 65 | $85,604.65 | $10,742.49 | $11,869.17 |
Hospital outpatient services by payment group (APC), 2024
| Service group | Services | Patients | Medicare pays per service | All hospitals |
|---|---|---|---|---|
| APC 5372 Level 2 Urology and Related Services | 1,355 | 720 | $188.80 | $502.15 |
| APC 5072 Level 2 Excision/ Biopsy/ Incision and Drainage | 596 | 559 | $438.72 | $1,219.56 |
| APC 5373 Level 3 Urology and Related Services | 580 | 460 | $633.80 | $1,516.28 |
| APC 8011 Comprehensive Observation Services | 446 | 425 | $633.23 | $2,090.36 |
| APC 5491 Level 1 Intraocular Procedures | 383 | 248 | $627.86 | $1,751.67 |
| APC 5431 Level 1 Nerve Procedures | 349 | 284 | $548.84 | $1,406.61 |
| APC 5183 Level 3 Vascular Procedures | 276 | 261 | $861.56 | $2,405.01 |
| APC 5115 Level 5 Musculoskeletal Procedures | 254 | 245 | $3,990.51 | $10,771.69 |
| APC 5073 Level 3 Excision/ Biopsy/ Incision and Drainage | 225 | 197 | $908.32 | $2,141.49 |
| APC 5374 Level 4 Urology and Related Services | 223 | 179 | $941.06 | $2,629.24 |
| APC 5191 Level 1 Endovascular Procedures | 217 | 216 | $847.36 | $2,207.96 |
| APC 5112 Level 2 Musculoskeletal Procedures | 216 | 197 | $325.58 | $1,196.16 |
Reported payments to this teaching hospital
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 22 | $1.0M |
| Genentech, Inc. ROG.SW | 28 | $716K |
| AstraZeneca Pharmaceuticals LP AZN | 10 | $342K |
| Vertex Pharmaceuticals Incorporated VRTX | 4 | $329K |
| Roche TCRC, Inc. ROG.SW | 14 | $327K |
| Eli Lilly and Company LLY | 6 | $274K |
| Medtronic, Inc. MDT | 42 | $198K |
| Merck Sharp & Dohme LLC MRK | 4 | $109K |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 24 | $95K |
| Boston Scientific Corporation BSX | 12 | $83K |
Official US government data on Original Medicare hospital stays and outpatient services; groups with fewer than 11 cases are not published. Payments are those drug and device companies must report.
Univ. of Vermont - Fletcher Allen Health Care is a nonprofit short-term acute care hospital in Burlington, VT with 469 beds, part of University of Vermont Health Network and a 4-star overall rating.
Univ. of Vermont - Fletcher Allen Health Care in Burlington, VT has 469 beds (fiscal year 2025 cost report); 615 beds are certified for Medicare. It discharged 21,027 inpatients that year, with 80.0% of its beds in use on average.
In fiscal year 2025 (ending 2025-09-30), Univ. of Vermont - Fletcher Allen Health Care reported net patient revenue of $1.43B and operating expenses of $2.45B, a margin on patient care of -71.0%. After other income and expenses its net income was -$212.0M (-9.5% of revenue), so it lost money that year.
Univ. of Vermont - Fletcher Allen Health Care is part of University of Vermont Health Network, a health system with 6 hospitals based in Burlington, VT. It is a nonprofit hospital.
Univ. of Vermont - Fletcher Allen Health Care has an overall rating of 4 out of 5 stars in the official hospital quality ratings. Patients rate it 4 out of 5 stars in the patient survey. 2 death rate measures are better and 0 worse than the national rate.
Yes, Univ. of Vermont - Fletcher Allen Health Care provides emergency services.
1,617 Medicare clinicians list Univ. of Vermont - Fletcher Allen Health Care as a hospital they work at, most often in Nurse Practitioner, Family Practice, Physician Assistant.
In 2024, Univ. of Vermont - Fletcher Allen Health Care had 5,222 Medicare inpatient stays in 158 diagnosis groups. The most common was DRG 871 (septicemia or severe sepsis without mv >96 hours with mcc) with 331 stays; Medicare paid $8,939.04 per stay on average, compared with $15,524.21 across all hospitals.
In 2025, companies reported $4.4M in payments to Univ. of Vermont - Fletcher Allen Health Care as a teaching hospital ($89K general and $4.3M for research) from 54 companies.